News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Renovaro Introduces Augusta, an AI-Powered Platform for Precision Neurology
Thursday, May 15, 2025Renovaro Inc a company focused on AIdriven precision medicine for cancer and neurological conditions has introduced Augusta a new platform designed to improve diagnosis treatment and research in neurology
FDA Grants Seven-Year Orphan-Drug Exclusivity for Ryoncil®
Thursday, May 15, 2025Mesoblast a global company specialising in allogeneic cellular medicines for inflammatory diseases has received seven years of orphandrug exclusivity from the US Food and Drug Administration FDA for its product Ryoncil remestemcelL This approval cove...
CellFE and Made Scientific Partner to Advance Non-Viral Gene Editing in T Cell Therapies
Wednesday, May 14, 2025CellFE a specialist in microfluidicsbased cell engineering has entered a strategic collaboration with Made Scientific a contract development and manufacturing organisation CDMO focused on cell therapies
Azenta Life Sciences and Form Bio Partner to Support AAV Gene Therapy Development
Wednesday, May 14, 2025Azenta Life Sciences has announced a strategic partnership between its GENEWIZ division and Form Bio an artificial intelligence AI life sciences technology company
Beam Therapeutics Receives U.S. FDA RMAT Designation for BEAM-302 to Treat Alpha-1 Antitrypsin Deficiency
Tuesday, May 13, 2025Beam Therapeutics Inc a biotechnology company focused on precision genetic medicine through base editing has received Regenerative Medicine Advanced Therapy RMAT designation from the United States Food and Drug Administration FDA for BEAM This invest...
ViVerita Therapeutics Collaborates with Boehringer Ingelheim to Advance Cancer Target Discovery
Thursday, May 08, 2025ViVerita Therapeutics a USbased company specialising in precision oncology has entered into a research collaboration with Boehringer Ingelheim to accelerate the identification and validation of new therapeutic targets for cancer treatment
Viralgen Partners with Trogenix to Advance AAV Gene Therapy for Glioblastoma
Wednesday, May 07, 2025Viralgen a leading contract development and manufacturing organisation CDMO specialising in recombinant adenoassociated virus rAAV gene therapies has entered into a strategic partnership with Trogenix a biotech company focused on developing innovativ...
Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug to Treat Tumour-Induced Hypoglycaemia
Tuesday, May 06, 2025Rezolute Inc a latestage company focused on rare diseases has received Breakthrough Therapy Designation BTD from the US Food and Drug Administration FDA for its investigational treatment ersodetug
Datavant Expands Partnership with Boehringer Ingelheim to Strengthen Real-World Evidence Capabilities
Monday, May 05, 2025Datavant has extended its partnership with Boehringer Ingelheim to support the pharmaceutical companys growing focus on realworld evidence RWE The collaboration will see Datavants data connectivity
Illumina and Ovation.io launch unique GLP-1 dataset to support development of new therapies
Friday, May 02, 2025Illumina Inc and Ovationio Inc have jointly announced the creation of a largescale clinical multiomic dataset focused on patients treated with glucagonlike peptide GLP receptor agonist therapies
